Venture Capital

A new FDA-cleared device uses water vapor to ablate prostate tissue, showing high efficacy in trials while minimizing life-altering side effects.

A new partnership aims to bring industrial-scale, clean-label cannabis extraction to the Garden State, promising a new standard for purity and consistency.

As child sextortion cases skyrocket, a new legal effort targets Snapchat's design, alleging it facilitates harm and fails to protect its youngest users.

Verkada's rapid global expansion and $5.8B valuation are powered by AI, but past security breaches and regulatory scrutiny cast a long shadow.

In its first-ever Match Day, the Kansas College of Osteopathic Medicine surpassed national averages, placing new doctors in critical primary care roles.

The space company quadruples its manufacturing space to chase defense contracts, but faces a tough financial reality and a crowded market.

Climative's new platform moves beyond risk scores, giving homeowners personalized plans to build resilience and helping insurers manage escalating losses.

With over $1B in orders, smart aircraft maker AIR is proving demand for personal and cargo eVTOLs is soaring, but regulatory hurdles remain.

With €10M in new funding, Berlin-based Cellbricks is moving its biofabricated human tissues from lab to preclinical trials, promising a new era for patients.

A new partnership uses advanced AI to find unused grid capacity, slashing data center connection times from years to months and accelerating economic growth.

With $138M in total funding, Endogenex is advancing a novel device that aims to redefine type 2 diabetes treatment by healing the gut, not just managing symptoms.

With a new $200M funding round, legal AI leader Harvey is now valued at $11 billion, signaling a fundamental shift in how law is practiced worldwide.

With a new $20M in funding, Charlotte-based Lucid Bots is expanding its fleet of AI-powered drones and robots, transforming blue-collar work from the ground up.

From the heart of Arabia, AlUla Peregrina brings a patented active to the global stage, promising scientifically-backed, ethical longevity beauty.

With the appointment of Wayne Grierson, Tixr is accelerating its push to disrupt Europe's legacy ticketing market with its modern commerce platform.

Struggling in the furniture market, XMax Inc. is making a bold leap into AI. But can a small furniture firm compete with tech giants?

Investors await East Side Games Group's year-end results to see if a costly Q3 investment in new titles will finally pay off and reverse recent losses.

Venture capital leaders and national security experts caution that drug pricing controls and regulatory hurdles could cede America's biomedical edge to rivals.

With its AI 'teammate' Harper, Wisq is automating HR tasks, pushing the profession from administrative burden to a strategic business powerhouse.

Serial entrepreneur Brett Adcock's new venture, Hark, aims to build the next computing platform with custom hardware and backing from NVIDIA and Apple talent.